PACB 1.8 (+1.69%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

53 / 58

Performance 5 years

43 / 58

Performance 10 years

40 / 58

Linearity 3 years

46 / 58

Linearity 5 years

15 / 58

Linearity 10 years

12 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Quick Ratio - PACB ranking 16 / 57

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by quick ratio
1. Anixa Biosciences ANIX
13.93
2. Co-Diagnostics CODX
12.85
3. MaxCyte MXCT
11.92
4. Global Cord Blood CO
10.64
5. Fulgent Genetics FLGT
8.51
6. DarioHealth DRIO
6.18
7. NeoGenomics NEO
5.78
8. Guardant Health GH
5.49
9. Twist Bioscience TWST
5.19
10. SeqLL SQL
5.01
11. Lantheus Holdings LNTH
4.95
12. Organovo Holdings ONVO
4.8
13. Olink Holding OLK
4.64
14. Exagen XGN
4.5
15. CareDx CDNA
4.4
16. Pacific Biosciences of California PACB
4.34
17. Personalis PSNL
4.14
18. Natera NTRA
4.11
19. Heska HSKA
3.81
20. Neuronetics STIM
3.57
21. Sera Prognostics SERA
3.42
22. bioAffinity Technologies BIAF
2.87
23. Qiagen QGEN
2.6
24. Enzo Biochem ENZ
2.54
25. DexCom DXCM
2.4
26. Prenetics Global PRE
2.32
27. MDxHealth MDXH
2.19
28. Neogen NEOG
2.16
29. Sotera Health SHC
2.1
30. Trinity Biotech TRIB
2.06
31. Exact Sciences EXAS
1.97
32. Agilent Technologies A
1.86
33. Danaher DHR
1.77
34. RadNet RDNT
1.3
35. Waters WAT
1.3
36. Aspira Womens Health AWH
1.3
37. Psychemedics PMD
1.18
38. Icon ICLR
1.14
39. Thermo Fisher Scientific TMO
1.13
40. Illumina ILMN
1.11
41. Syneos Health SYNH
1.1
42. Ortho Clinical Diagnostics Holdings OCDX
1.1
43. Laboratory Corp of America Holdings LH
0.96
44. Myriad Genetics MYGN
0.96
45. Charles River Laboratories CRL
0.96
46. Inotiv NOTV
0.94
47. IDEXX Laboratories IDXX
0.88
48. Quest Diagnostics DGX
0.88
49. Bioventus BVS
0.87
50. Interpace Biosciences IDXG
0.8
51. Biodesix BDSX
0.79
52. IQVIA Holdings IQV
0.7
53. PerkinElmer PKI
0.69
54. Mettler-Toledo MTD
0.66
55. Precipio PRPO
0.56
56. National Research NRC
0.46
57. Medpace Holdings MEDP
0.46
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.